#angiodynamics search results

Aquilant was delighted to support the @BSIR_News in Liverpool, together with our partners #Optimed and #Cardionovum. We also contributed to the Active Learning Zone, showcasing liquid embolics, NanoKnife IRE system from #AngioDynamics, and #TaeWoong Niti-S stents.

21Healthcare's tweet image. Aquilant was delighted to support the @BSIR_News in Liverpool, together with our partners #Optimed and #Cardionovum. 
 
We also contributed to the Active Learning Zone, showcasing liquid embolics, NanoKnife IRE system from #AngioDynamics, and #TaeWoong Niti-S stents.

Behind every statistic is a story. Behind every story is a reason. This Vascular Disease Awareness Month, we stand with patients, families, and caregivers—because one reason is enough to care. #OneReason #AngioDynamics #VascularAwarenessMonth #VascularHealth #MedTech


Congratulations to Dr. Matt Finn and the team at @CardioInstitute for enrolling their first patient in #AMBITIONBTK!     Learn more▶️ bit.ly/464ZJTE   Risk information▶️ bit.ly/3UFe4Rf #AngioDynamics #Auryon #TheAuryonSystem

AngioDynamicsCV's tweet image. Congratulations to Dr. Matt Finn and the team at @CardioInstitute for enrolling their first patient in #AMBITIONBTK! 
  
Learn more▶️ bit.ly/464ZJTE
 
Risk information▶️ bit.ly/3UFe4Rf
#AngioDynamics #Auryon #TheAuryonSystem

We’re proud to announce that the AngioDynamics NanoKnife® System has been named one of @TIME’s Best Inventions of 2025. See the full list ▶️ time.com/collections/be… #AngioDynamics #NanoKnife #TIMEBestInventions #TIME #BestInventions2025 Risk information: bit.ly/3UFe4Rf

angiodynamics's tweet image. We’re proud to announce that the AngioDynamics NanoKnife® System has been named one of @TIME’s Best Inventions of 2025.

See the full list ▶️ time.com/collections/be…

#AngioDynamics #NanoKnife #TIMEBestInventions #TIME #BestInventions2025
Risk information: bit.ly/3UFe4Rf

Big news in focal therapy: Nanoknife has been named one of @TIME's Best Inventions of 2025. This recognition reflects the innovative work being done in the ever-evolving field of focal therapy #NanoKnife #AngioDynamics #ProstateCancer #Urology loom.ly/qVo2yOA


President and CEO Jim Clemmer was featured on a recent episode of Let’s Talk Medtech ▶️ mddionline.com/cardiovascular… @MDDIonline #AngioDynamics #MedTech #LetsTalkMedtech Risk info > bit.ly/3UFe4Rf

angiodynamics's tweet image. President and CEO Jim Clemmer was featured on a recent episode of Let’s Talk Medtech ▶️ mddionline.com/cardiovascular… 

@MDDIonline
#AngioDynamics #MedTech #LetsTalkMedtech
Risk info > bit.ly/3UFe4Rf

Excited to be part of a special moment for our company yesterday! Could not be more proud to be part of the team #angiodynamics

Angio_romosam's tweet image. Excited to be part of a special moment for our company yesterday! Could not be more proud to be part of the team #angiodynamics

#ango #NASDAQ #AngioDynamics 25-30 yıllık grafikte diplerde

0mr_0ztrk's tweet image. #ango #NASDAQ #AngioDynamics 
25-30 yıllık grafikte diplerde

Happy Valentine’s Day to all our Heart 🫀champions from us at #Angiodynamics We are grateful for endless medical puns today and for all that you do for your patients!

Angio_romosam's tweet image. Happy Valentine’s Day to all our Heart 🫀champions from us at #Angiodynamics We are grateful for endless medical puns today and for all that you do for your patients!

It’s exciting to see new sites join #AMBITIONBTK – congratulations to Dr. Guevara and the team at Barnes Jewish Hospital on their first patient enrollment! Learn more> bit.ly/464ZJTE Risk information> bit.ly/3UFe4Rf #AngioDynamics #TheAuryonSystem #AMBITIONBTK

AngioDynamicsCV's tweet image. It’s exciting to see new sites join #AMBITIONBTK – congratulations to Dr. Guevara and the team at Barnes Jewish Hospital on their first patient enrollment!

Learn more> bit.ly/464ZJTE
Risk information> bit.ly/3UFe4Rf

#AngioDynamics #TheAuryonSystem #AMBITIONBTK

#AngioDynamics #NASDAQ #ANGO a leading #medicaltechnology company specializing in vascular health and cancer #treatment, recently announced its financial results for the fourth quarter and fiscal year 2023. This article highlights key information from the company's fourth-quarter

WellthyAi's tweet image. #AngioDynamics #NASDAQ #ANGO a leading #medicaltechnology company specializing in vascular health and cancer #treatment, recently announced its financial results for the fourth quarter and fiscal year 2023. This article highlights key information from the company's fourth-quarter

#AngioDynamics $ANGO #Q4 #earnings : Revenue up 4.7% YoY to $91.1M, driven by strong growth in Med Tech segment. Auryon PAD business soars with 41% revenue increase! #MedTech #FinancialResults #EarningsCall prospermetrics.com/investorbriefs…

Finmake_over's tweet image. #AngioDynamics $ANGO #Q4 #earnings : Revenue up 4.7% YoY to $91.1M, driven by strong growth in Med Tech segment. Auryon PAD business soars with 41% revenue increase! #MedTech #FinancialResults #EarningsCall

prospermetrics.com/investorbriefs…

I was on the launch team for #NanoKnife in 2008 and now representing #Epione Robot it brings me great joy to see these 2 technologies used in conjunction for the FIRST TIME EVER in the world!!! Great work Prof. Laurent Milot! #AngioDynamics #QuantumSurgical #ablation #IRE

AndrewRoboticIO's tweet image. I was on the launch team for #NanoKnife in 2008 and now representing #Epione Robot it brings me great joy to see these 2 technologies used in conjunction for the FIRST TIME EVER in the world!!! 

Great work Prof. Laurent Milot! 
 #AngioDynamics  #QuantumSurgical #ablation #IRE

Congratulations to Dr. Matt Finn and the team at @CardioInstitute for enrolling their first patient in #AMBITIONBTK!     Learn more▶️ bit.ly/464ZJTE   Risk information▶️ bit.ly/3UFe4Rf #AngioDynamics #Auryon #TheAuryonSystem

AngioDynamicsCV's tweet image. Congratulations to Dr. Matt Finn and the team at @CardioInstitute for enrolling their first patient in #AMBITIONBTK! 
  
Learn more▶️ bit.ly/464ZJTE
 
Risk information▶️ bit.ly/3UFe4Rf
#AngioDynamics #Auryon #TheAuryonSystem

Aquilant was delighted to support the @BSIR_News in Liverpool, together with our partners #Optimed and #Cardionovum. We also contributed to the Active Learning Zone, showcasing liquid embolics, NanoKnife IRE system from #AngioDynamics, and #TaeWoong Niti-S stents.

21Healthcare's tweet image. Aquilant was delighted to support the @BSIR_News in Liverpool, together with our partners #Optimed and #Cardionovum. 
 
We also contributed to the Active Learning Zone, showcasing liquid embolics, NanoKnife IRE system from #AngioDynamics, and #TaeWoong Niti-S stents.

It’s exciting to see new sites join #AMBITIONBTK – congratulations to Dr. Guevara and the team at Barnes Jewish Hospital on their first patient enrollment! Learn more> bit.ly/464ZJTE Risk information> bit.ly/3UFe4Rf #AngioDynamics #TheAuryonSystem #AMBITIONBTK

AngioDynamicsCV's tweet image. It’s exciting to see new sites join #AMBITIONBTK – congratulations to Dr. Guevara and the team at Barnes Jewish Hospital on their first patient enrollment!

Learn more> bit.ly/464ZJTE
Risk information> bit.ly/3UFe4Rf

#AngioDynamics #TheAuryonSystem #AMBITIONBTK

Big news in focal therapy: Nanoknife has been named one of @TIME's Best Inventions of 2025. This recognition reflects the innovative work being done in the ever-evolving field of focal therapy #NanoKnife #AngioDynamics #ProstateCancer #Urology loom.ly/qVo2yOA


We’re proud to announce that the AngioDynamics NanoKnife® System has been named one of @TIME’s Best Inventions of 2025. See the full list ▶️ time.com/collections/be… #AngioDynamics #NanoKnife #TIMEBestInventions #TIME #BestInventions2025 Risk information: bit.ly/3UFe4Rf

angiodynamics's tweet image. We’re proud to announce that the AngioDynamics NanoKnife® System has been named one of @TIME’s Best Inventions of 2025.

See the full list ▶️ time.com/collections/be…

#AngioDynamics #NanoKnife #TIMEBestInventions #TIME #BestInventions2025
Risk information: bit.ly/3UFe4Rf

President and CEO Jim Clemmer was featured on a recent episode of Let’s Talk Medtech ▶️ mddionline.com/cardiovascular… @MDDIonline #AngioDynamics #MedTech #LetsTalkMedtech Risk info > bit.ly/3UFe4Rf

angiodynamics's tweet image. President and CEO Jim Clemmer was featured on a recent episode of Let’s Talk Medtech ▶️ mddionline.com/cardiovascular… 

@MDDIonline
#AngioDynamics #MedTech #LetsTalkMedtech
Risk info > bit.ly/3UFe4Rf

Behind every statistic is a story. Behind every story is a reason. This Vascular Disease Awareness Month, we stand with patients, families, and caregivers—because one reason is enough to care. #OneReason #AngioDynamics #VascularAwarenessMonth #VascularHealth #MedTech


REMINDER: Cardiovascular Pitch Submission Now Open! Submission Deadline: September 15, 2025 🔗Use the following link to Submit your pitch now: angiodynamics.com/improving-care… #CVSF2025 #Innovation #AngioDynamics #MedTech #CardiovascularCare

angiodynamics's tweet image. REMINDER: Cardiovascular Pitch Submission Now Open!

Submission Deadline: September 15, 2025

🔗Use the following link to Submit your pitch now: angiodynamics.com/improving-care…

#CVSF2025 #Innovation #AngioDynamics #MedTech #CardiovascularCare

Only a few more days to come see the Auryon team! Visit us at Booth 302. Learn more about the Auryon System ▶️ bit.ly/47aRiYV @AMPSymposium #AMP2025 #AngioDynamics #Auryon #TheAuryonSystem Risk Info: bit.ly/3IOQLC2

AngioDynamicsCV's tweet image. Only a few more days to come see the Auryon team! 

Visit us at Booth 302. 

Learn more about the Auryon System ▶️ bit.ly/47aRiYV

@AMPSymposium 
#AMP2025 #AngioDynamics #Auryon #TheAuryonSystem

Risk Info: bit.ly/3IOQLC2

We look forward to an event of engaging sessions, expert clinical and scientific perspectives, and meaningful insights. Visit the #Auryon team at Booth 302. ▶️ bit.ly/47aRiYV @AMPSymposium #AngioDynamics #TheAuryonSystem #AMP2025 Risk Info: bit.ly/3IOQLC2

AngioDynamicsCV's tweet image. We look forward to an event of engaging sessions, expert clinical and scientific perspectives, and meaningful insights.

Visit the #Auryon team at Booth 302. 

▶️ bit.ly/47aRiYV

@AMPSymposium 
#AngioDynamics #TheAuryonSystem #AMP2025

Risk Info: bit.ly/3IOQLC2

Chemo Port Infection Lawsuits Over Bard, AngioDynamics Catheters Allege Faulty Design Promotes Bacterial Growth #ChemoPort #BardPowerPort #AngioDynamics aboutlawsuits.com/bard-powerport…


Aquilant was delighted to support the @BSIR_News in Liverpool, together with our partners #Optimed and #Cardionovum. We also contributed to the Active Learning Zone, showcasing liquid embolics, NanoKnife IRE system from #AngioDynamics, and #TaeWoong Niti-S stents.

21Healthcare's tweet image. Aquilant was delighted to support the @BSIR_News in Liverpool, together with our partners #Optimed and #Cardionovum. 
 
We also contributed to the Active Learning Zone, showcasing liquid embolics, NanoKnife IRE system from #AngioDynamics, and #TaeWoong Niti-S stents.

Congratulations to Dr. Matt Finn and the team at @CardioInstitute for enrolling their first patient in #AMBITIONBTK!     Learn more▶️ bit.ly/464ZJTE   Risk information▶️ bit.ly/3UFe4Rf #AngioDynamics #Auryon #TheAuryonSystem

AngioDynamicsCV's tweet image. Congratulations to Dr. Matt Finn and the team at @CardioInstitute for enrolling their first patient in #AMBITIONBTK! 
  
Learn more▶️ bit.ly/464ZJTE
 
Risk information▶️ bit.ly/3UFe4Rf
#AngioDynamics #Auryon #TheAuryonSystem

We’re proud to announce that the AngioDynamics NanoKnife® System has been named one of @TIME’s Best Inventions of 2025. See the full list ▶️ time.com/collections/be… #AngioDynamics #NanoKnife #TIMEBestInventions #TIME #BestInventions2025 Risk information: bit.ly/3UFe4Rf

angiodynamics's tweet image. We’re proud to announce that the AngioDynamics NanoKnife® System has been named one of @TIME’s Best Inventions of 2025.

See the full list ▶️ time.com/collections/be…

#AngioDynamics #NanoKnife #TIMEBestInventions #TIME #BestInventions2025
Risk information: bit.ly/3UFe4Rf

It’s exciting to see new sites join #AMBITIONBTK – congratulations to Dr. Guevara and the team at Barnes Jewish Hospital on their first patient enrollment! Learn more> bit.ly/464ZJTE Risk information> bit.ly/3UFe4Rf #AngioDynamics #TheAuryonSystem #AMBITIONBTK

AngioDynamicsCV's tweet image. It’s exciting to see new sites join #AMBITIONBTK – congratulations to Dr. Guevara and the team at Barnes Jewish Hospital on their first patient enrollment!

Learn more> bit.ly/464ZJTE
Risk information> bit.ly/3UFe4Rf

#AngioDynamics #TheAuryonSystem #AMBITIONBTK

Excited to be part of a special moment for our company yesterday! Could not be more proud to be part of the team #angiodynamics

Angio_romosam's tweet image. Excited to be part of a special moment for our company yesterday! Could not be more proud to be part of the team #angiodynamics

#ango #NASDAQ #AngioDynamics 25-30 yıllık grafikte diplerde

0mr_0ztrk's tweet image. #ango #NASDAQ #AngioDynamics 
25-30 yıllık grafikte diplerde

President and CEO Jim Clemmer was featured on a recent episode of Let’s Talk Medtech ▶️ mddionline.com/cardiovascular… @MDDIonline #AngioDynamics #MedTech #LetsTalkMedtech Risk info > bit.ly/3UFe4Rf

angiodynamics's tweet image. President and CEO Jim Clemmer was featured on a recent episode of Let’s Talk Medtech ▶️ mddionline.com/cardiovascular… 

@MDDIonline
#AngioDynamics #MedTech #LetsTalkMedtech
Risk info > bit.ly/3UFe4Rf

#AngioDynamics $ANGO #Q4 #earnings : Revenue up 4.7% YoY to $91.1M, driven by strong growth in Med Tech segment. Auryon PAD business soars with 41% revenue increase! #MedTech #FinancialResults #EarningsCall prospermetrics.com/investorbriefs…

Finmake_over's tweet image. #AngioDynamics $ANGO #Q4 #earnings : Revenue up 4.7% YoY to $91.1M, driven by strong growth in Med Tech segment. Auryon PAD business soars with 41% revenue increase! #MedTech #FinancialResults #EarningsCall

prospermetrics.com/investorbriefs…

#AngioDynamics #NASDAQ #ANGO a leading #medicaltechnology company specializing in vascular health and cancer #treatment, recently announced its financial results for the fourth quarter and fiscal year 2023. This article highlights key information from the company's fourth-quarter

WellthyAi's tweet image. #AngioDynamics #NASDAQ #ANGO a leading #medicaltechnology company specializing in vascular health and cancer #treatment, recently announced its financial results for the fourth quarter and fiscal year 2023. This article highlights key information from the company's fourth-quarter

#AngioVac training sessions were a huge success & we provided comprehensive training to clinical teams across the UK. We were honoured to have Kurt Bores from #AngioDynamics in the US join us for the week, visiting our customers to offer expert advice & hands-on training.

21Healthcare's tweet image. #AngioVac training sessions were a huge success & we provided comprehensive training to clinical teams across the UK. We were honoured to have Kurt Bores from #AngioDynamics in the US join us for the week, visiting our customers to offer expert advice & hands-on training.

Happy Valentine’s Day to all our Heart 🫀champions from us at #Angiodynamics We are grateful for endless medical puns today and for all that you do for your patients!

Angio_romosam's tweet image. Happy Valentine’s Day to all our Heart 🫀champions from us at #Angiodynamics We are grateful for endless medical puns today and for all that you do for your patients!

As proud sponsors of the #AngioDynamics #LifeThrouthPartnership Congress in Rome, we are super excited and ready to engage with clinicians and explore distribution opportunities over the next few days. Come and see Jas, Maria and Chris on the #Kimal stand!

KimalPlc's tweet image. As proud sponsors of the #AngioDynamics #LifeThrouthPartnership Congress in Rome, we are super excited and ready to engage with clinicians and explore distribution opportunities over the next few days.
Come and see Jas, Maria and Chris on the #Kimal stand!

A man undergoing chemotherapy needed surgery to remove his Xcela Port Catheter after developing blood clots and other complications. #Xcela #AngioDynamics #MDL #Chemotherapy - dailyhornet.com/2025/cancer-pa…

dailyhornetnews's tweet image. A man undergoing chemotherapy needed surgery to remove his Xcela Port Catheter after developing blood clots and other complications. #Xcela #AngioDynamics #MDL #Chemotherapy - dailyhornet.com/2025/cancer-pa…

Excited to share that #AngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System! Learn more at lnkd.in/dnsbfdRd #thrombectomy #medicaldevice #angiovac

Angio_romosam's tweet image. Excited to share that #AngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System! Learn more at lnkd.in/dnsbfdRd

#thrombectomy #medicaldevice #angiovac

#AngioDynamics, $ANGO, Q1 FY25 Results: 🟢+1.4% Pre Market ($7.76) 📊 Adj EPS: $(0.11) 🟢 💰 Revenue: $67.50M 🔴 📉 Net Loss: $(12.80)M 🔍 Med Tech net sales grew 8.7%, driven by strong performance in Auryon and AlphaVac platforms.

Earnings_Time's tweet image. #AngioDynamics, $ANGO, Q1 FY25 Results:
🟢+1.4% Pre Market ($7.76)

📊 Adj EPS: $(0.11) 🟢
💰 Revenue: $67.50M 🔴
📉 Net Loss: $(12.80)M
🔍 Med Tech net sales grew 8.7%, driven by strong performance in Auryon and AlphaVac platforms.

Gearing up for the #AngioDynamics #LifeThroughPartnership Congress, which starts tomorrow in Monte Carlo and runs until Saturday. The #Kimal team looks forward to seeing you at our exhibition stand. #montecarlo

KimalPlc's tweet image. Gearing up for the #AngioDynamics #LifeThroughPartnership Congress, which starts tomorrow in Monte Carlo and runs until Saturday. The #Kimal team looks forward to seeing you at our exhibition stand.

#montecarlo

Loading...

Something went wrong.


Something went wrong.


United States Trends